6th ANNUAL REPORT 2012-2013 - ONGC TERI Biotech Ltd · 6th annual report 2012-2013 four stages of...
Transcript of 6th ANNUAL REPORT 2012-2013 - ONGC TERI Biotech Ltd · 6th annual report 2012-2013 four stages of...
6th
ANNUAL REPORT
2012-2013
FOUR STAGES OF BIOREMEDIATION
ONGC TERI Biotech Limited (A ISO-9001:2008, ISO-14001:2004, OHSAS-18001:2007 CERTIFIED COMPANY)
AN ISO9001:2008;
14001:2004&18001:2007
CERTIFIED COMPANY
Reg. No. : RI91/7445
ONGC TERI Biotech Limited
BOARD OF DIRECTORS
Shri N.K.Verma Chairman (From 03.05.2013)
Shri S.V.Rao Chairman (From 31.12.2012 to 31.03.2013)
Shri A.K.Hazarika Chairman (Up to 01.10.2012)
Dr. Banwari Lal Director & CEO
Shri M.M.Joshi Director
Dr. D.M.Kale Director
Dr. R. V. Marathe Director (Up to 22.06.2012)
Shri Anoop Kumar Director (Up to 01.11.2012)
Shri R.K.Sharma Director (From 22.06.2012)
Shri M.L.Jain Director (From 31.12.2012)
STATUTORY AUDITORS
M/s A. K. Khurana & Associates
Chartered Accountants,
New Delhi
BANKERS
State Bank of Hyderabad,
Lodhi Road, New Delhi
REGISTERED OFFICE
The Energy and Resources Institute,
Darbari Seth Block, IHC Complex,
Lodhi Road, New Delhi-110003
ONGC TERI Biotech Limited
NOTICE
NOTICE is hereby given that the 6th Annual General Meeting of the Members of ONGC TERI
Biotech Limited will be held on Friday, the 27th September,2013 at 15.00 Hrs. at 7th Floor,
Conference Room, ONGC, Jeevan Bharti, Tower-II, 124, Indira Chowk, New Delhi-110001, to
transact the following Business;
As Ordinary Business:
1. To receive, consider and adopt the Audited Balance Sheet as at 31st March, 2013 and
the Profit and Loss Account of the Company for the financial year ended on that date
together with the Reports of the Directors and the Auditors thereon.
2. To appoint a Director in place of Shri N. K. Verma retires by rotation and being eligible,
offers himself for re-appointment.
3. To appoint a Director in place of Shri M. M. Joshi who retires by rotation and being
eligible, offers himself for reappointment.
As Special Business:
4. To consider and if thought fit, to pass with or without modification(s), the following as a Special
Resolution:
“RESOLVED THAT pursuant to section 224A of the Companies Act, 1956, (including any
statutory modification or re-enactment thereof for the time being in force and as may
be enacted from time to time) M/s A. K. Khurana & Associates, Chartered Accountants,
Membership No.084245, the retiring Statutory Auditors of the Company from whom the
Company has received a Certificate under Section 224 (1)(B) of the Act, being eligible,
be and are hereby, re-appointed as the Statutory Auditors of the Company to hold
office from the conclusion of this meeting until the conclusion of the next Annual
General Meeting of the Company at a remuneration of Rs.75,000/- exclusive of the
applicable Service Tax and out of pocket expenses.”
By Order of the Board of Directors
for ONGC TERI Biotech Limited
Sd/-
Place: New Delhi (Dr. Banwari Lal)
Date: 27th September, 2013 Director & CEO
NOTES:
1. A Member entitled to attend and vote at the meeting is entitled to appoint a Proxy to attend and vote instead of himself
and the Proxy need not be a Member of the Company. Proxies in order to be effective must be received by the
Company not less than forty-eight hours before the meeting.
2. The relevant Explanatory Statement pursuant to Section 173(2) of the Companies Act, 1956 in respect of item no. 4 stated
above is annexed hereto.
ONGC TERI Biotech Limited
EXPLANATORY STATEMENT PURSUANT TO SECTION 173(2) OF THE COMPANIES ACT, 1956
Item No. 4
As per section 224A of the Companies Act, 1956, the re-appointment of an auditor shall be
made by a Special Resolution since Oil and Natural Gas Corporation Limited, a
Government Company holds more than 25% (Twenty-five) of the Subscribed Capital of the
Company.
The Board of Directors recommends the resolution for your approval as a Special Resolution.
None of the Directors of the Company is in any way concerned or interested in the
resolution.
By Order of the Board of Directors
for ONGC TERI Biotech Limited
Sd/-
Place: New Delhi (Dr. Banwari Lal)
Date: 27th September, 2013 Director & CEO
ONGC TERI Biotech Limited
DIRECTORS’ REPORT
Dear Members,
Your Directors are pleased to present the 6th Annual Report together with the Audited
Accounts of the Company for the period ending on 31st March, 2013.
Financial Results
The Company has followed the Project Completion method for recognizing revenue.
Based on Projects closed, your Company during the year has generated gross revenue of
Rs. 1,366.05 lakhs (Previous year - Rs. 1,299.62lakhs). After meeting the operational & other
expenses, after tax carried forward net profit of your Company is Rs. 400.48 lakhs (Previous
year - Rs. 327.85 lakhs).
Dividend
Your Directors do not recommend payment of any dividend for the period ended 31st
March, 2013.
Operations Highlights
Your Company which was set-up as a Joint-Venture of Oil and Natural Gas Corporation
Ltd., (ONGC) and The Energy and Resources Institute (TERI) continues to provide oil field
services to the Oil and Gas Industry using microbial methods primarily in four areas,
namely:
1. Bio-remediation using Oilzapper Technology;
2. Microbial Enhanced Oil Recovery;
3. Application of Paraffin Deposition Bacteria (PDB) technology to prevent
chocking of Production Tubing; and
4. Wax Deposition Prevention (WDP) in flow lines.
Order Book
(i) Bioremediation Jobs
Your Company during the year successfully executed the Bio-remediation job by
use of “Oilzapper” Technology at following sites:
i) Oil India Limited, Duliajan - 9000 MT. of Oily Sludge
ii) ONGC, Mehsana Asset - 15000 MT. of Oily Sludge
iii) ONGC, Ankleshwar Asset - 250 MT. of Oily Sludge
ONGC TERI Biotech Limited
Making of a Secured Pit Sprinkling of OILZAPPER
The following work orders, which are under execution by your Company, were also
received during the year:
i) ONGC Ankleshwar Asset - 14,910 MT. of Oily Sludge
ii) ONGC Nazira Asset - 22,984 MT. of Oily Sludge
Before application of Oilzapper After final application of Oilzapper
at OIL, Duliajan at OIL , Duliajan
(ii) Microbial Enhanced Oil Recovery (MEoR)
Execution of Microbial Enhanced Oil Recovery (MEoR) job in 12 wells of ONGC
Ankleshwar Asset was completed by your Company during the year.
ONGC TERI Biotech Limited
Execution of MEOR job in oil wells HOC/CTU job at GLK#160
Execution of MeOR job in Oil Wells
(iii) Wax Deposition Prevention (WDP)/ Paraffin Degrading Bacterial (PDB)
During the year, your Company successfully completed Wax Deposition
Prevention (WDP) job in about 15.7 KM of flow line and Asphaltane Degrading
Bacterial (ADB) job in 4 wells of ONGC, Mehsana Asset, respectively. Job order for
Paraffin Degrading Bacterial (PDB) in 30 wells from ONGC, Assam Asset also
received during the year was under execution.
Execution
Execution of PDB job in Oil Wells
Rate Contract
During the year your Company entered into a long-term three years Rate Contract with
ONGC valid up to December 4, 2015 wherein your Company shall carry out
Bioremediation of approximately 75,000 MT of oily sludge/oil soaked soil at various work
centres of ONGC. The Rate Contract is valued at an estimated value of Rs. 21, 06,
70,000/- (Rupees Twenty One Crore Six Lacs Seventy Thousands, only), and will
ensure continuous flow of job orders for Bioremediation over its full term.
ONGC TERI Biotech Limited
Future Outlook
The order book of your Company continues to be overflowing with several proposals in
pipeline and nearing maturity.
The First International work order of the estimated contract value of Rs.3.50 Crore for
Bioremediation of 15,000 Cubic Meters of waste sludge oil and contaminated solids at
Canadian Nexen Petroleum, Yemen received by your Company, is under execution.
ISO Certificate of Compliance
During the year, your Company successfully completed the 1st Surveillance Audit and the
Certificate for its Integrated Management System for „Providing & Promoting
Biotechnological Solutions to Oil and Gas Industry‟, being compliant with the
requirements of International Standards of quality Management System-ISO 9001:2008;
Environmental Management System- ISO14001:2004 and Occupational Health and Safety
Management System-OHSAS18001:2007 was renewed by the International Certification
Services Pvt. Ltd.,(ICS). The Certificate is valid for Three years i.e., up to 15th March, 2015.
Authorization of Bioremediation Services by PCB, Assam
Your Directors are pleased to inform that Pollution Control Board, Assam has granted
initial authorization under provisions of Rules5 (4) of Hazardous Waste (Management,
Handling & Transboudary Movement) Rules, 2008 for collection, reception, treatment,
transportation & storage of Hazardous Wastes (oily Sludge) during the Bio-remediation of
sludge pits at various sites through out Assam . The initial authorization will be for a period
of two years.
Fixed Deposit
The Company has not accepted any Fixed Deposits from the public.
Auditors
M/s A.N. Khurana & Associates, Chartered Accountants, New Delhi, Statutory Auditors of
the Company holds office until the conclusion of the forthcoming Annual General
Meeting of the Company and are recommended for reappointment. The Company has
received certificate from them to the effect that their appointment, if made, would be
within the provisions of Section 224(1) of the Companies Act, 1956.
There is no qualification in the Auditors‟ Report for the year ended 31st March, 2013.
Particulars of Employees
There is no employee in the Company whose particulars are required to be given under
Section217 (2A) of the Companies Act, 1956.
ONGC TERI Biotech Limited
Particulars of Conservation of Energy, Technology Absorption etc.
Your Company while providing bioremediation solutions to the Oil and Gas Industry is
continuously endeavouring to develop most energy efficient processes and devices.
Wherever possible, energy conservation measures have been implemented. For
example, use of low pressure pumps to send environmental friendly microbial solution for
recovery of trapped oil in the reservoirs; use of microbial system to form bio-films in the
pipelines preventing paraffin deposition for considerable time and eliminating use of
energy sapping drilling instruments, shut-down of operations and use of energy intensive
mechanical scrappers; microbes using toxic waste as source of nutrients and converting
the same to compost, requiring no external energy and the wastes converted to CO2,
water and bacterial biomass, etc. Microbial methods used are thus latest in the fast
evolving field of bioremediation solutions backed by robust research and development.
Effort to conserve & optimize use of energy and absorb new techniques is a continuous
process in your Company. The Company has neither earned nor spent any foreign
exchange during the accounting period ended 31st March, 2013.
Directors’ Responsibility Statement
As required under Section 217 (2AA) of the Companies Act, 1956, your Directors state
that:
(i) that in the preparation of the Annual Accounts, the applicable accounting
standards have been followed;
(ii) that the accounting policies selected and applied are consistent and the
judgment and estimates made are reasonable and prudent so as to give a
true and fair view of the state of affairs of the Company at the end of the
financial year and of the profit or loss of the Company for that period;
(iii) that proper and sufficient care has been taken for the maintenance of
adequate accounting records in accordance with the provisions of the
Companies Act, 1956 for safeguarding the assets of the Company and for
preventing and detecting fraud and other irregularities;
(iv) that the Annual Accounts have been prepared on a going concern basis.
Directors
Shri A. K. Hazarika, First Chairman of your Company, ceased to be a Director on the
Board of your Company w.e.f 1st October, 2012. Your Board of Directors place on record
its appreciation of the advice, guidance and yeoman services provided by him in the
initial and formatives years of your Company.
Dr. R. V. Marathe and Shri Anoop Kumar also ceased to be Directors on the Board w.e.f.
22nd June & 1st November, 2012, respectively. Your Board of Directors place on record its
appreciation of the guidance, support and the contribution made by them during the
tenure they were Directors on the Board.
ONGC TERI Biotech Limited
Shri S. V. Rao, who was appointed Chairman of the Board of Directors w.e.f. 31st
December, 2012 ceased to be a Director on the Board w.e.f. 31st March, 2013. Your
Board of Directors places on record its appreciation of the guidance provided by him
during the short duration he was a Director on the Board.
During the year, Shri N. K. Verma joined as Chairman of the Board of Director w.e.f.3rd
May, 2013. S/Shri R. K. Shrma and M. L. Jain also joined your Board of Directors w.e.f.22nd
June & 31st December, 2012, respectively.
In accordance with the provisions of the Companies Act, 1956 and the Articles of
Association of the Company, S/Shri N. K. Verma and M. M. Joshi, Directors retire by
rotation and being eligible, offer themselves for re-appointment.
None of the Directors are disqualified from being appointed as Directors in terms of
provisions of Section 274(1) (g) of the Companies Act, 1956.
Acknowledgements
The Directors wish to thank and deeply acknowledge the co-operation, assistance and
support extended by ONGC, TERI and other shareholders, Company‟s bankers and
Statutory Auditors etc. The Directors also wish to place on record their appreciation of the
contribution made at all levels by the employees of your Company.
Regd. Office: On behalf of the Board of Directors
for ONGC TERI Biotech Limited
The Energy and Resources Institute,
Darbari Seth Block, IHC Complex,
Lodhi Road, New Delhi-110003 Sd/-
(N.K. Verma)
Date: 27TH September, 2013 Chairman
ONGC TERI Biotech Limited
AUDITOR’S REPORT
The Shareholders of ONGC TERI BIOTECH LIMITED
We have audited the attached Balance Sheet of ONGC TERI BIOTECH LIMITED as
at 31st March, 2013, the Statement of Profit and Loss and the Cash Flow Statement
for the year ended on that date annexed thereto. These financial statements are
the responsibility of the Company‟s management. Our responsibility is to express
an opinion on these financial statements based on our audit.
We conducted our audit in accordance with auditing standards generally
accepted in India. Those standards require that we plan and perform the audit to
obtain reasonable assurance about whether the financial statements are free of
material misstatement. An audit includes examining, on a test basis, evidence
supporting the amounts and the disclosures in the financial statements. An audit
also includes assessing the accounting principles used and significant estimates
made by management, as well as evaluating the overall financial statement
presentation. We believe that our audit provides a reasonable basis for our
opinion.
As required by the Companies (Auditor‟s Report) order 2003 issued by the Central
Government of India in terms of Section (4A) of Section 227 of the Companies
Act 1956, we enclose in the annexure a statement on the matters specified in
paragraphs 4 & 5 of the said order.
Further to our comments in the Annexure referred to above, we report that:
i) We have obtained all the information and explanations which to the
best of our knowledge and belief were necessary for the purpose of our
audit.
ii) In our opinion, proper Books of Account as required by law have been
kept by the Company so far as it appears from our examination of such
books;
iii) The Balance Sheet, the Statement of Profit and Loss Account and the
Cash flow Statement dealt with by this report are in agreement with the
Books of Account;
iv) In our opinion, the Balance Sheet, the Statement of Profit and Loaa and
the Cash Flow Statement dealt with by this report comply with the
Accounting Standards referred to in sub-section (3C) of Section 211 of
the Companies Act, 1956.
ONGC TERI Biotech Limited
v) On the basis of written representations received from the Directors, as on 31st
March 2012, and taken on record by the Board of Directors, we report that
none of the Directors is disqualified as on 31st March 2013 from being
appointed as a director in terms of clause (g) of sub-section (1) of section 274
of the Companies Act, 1956.
vi) In our opinion and to the best of our information and according to the
explanations given to us, the said accounts give the information required by
the Companies Act, 1956, in the manner so required and give a true and fair
view in conformity with the accounting principles generally accepted in India:
(a) In the case of the Balance Sheet, of the State of Affairs of the
Company as at 31st March, 2013;
(b) In the case of the Profit and Loss Statement, of the Profit for the
year ended on that date.
(c) In the case of the Cash Flow Statement, of the cash flows of the
Company for the year ended on that date.
For A.K.KHURANA & ASSOCIATES
CHARTERED ACCOUNTANTS
(Registration No.00537IN)
Sd/-
Place: New Delhi (ASHOK KHURANA)
Date: 3rd May, 2013 SOLE PRACTITIONER
Membership No.: 084245
ONGC TERI Biotech Limited
ANNEXURE TO AUDITOR’S REPORT
1. a) The Company has maintained proper records showing full particulars including
quantitative details and situation of fixed assets.
b) The Company has a programme of physical verification of fixed assets which is,
in our opinion, reasonable having regard to the size of the Company and the
nature of its assets. In accordance with this programme, certain fixed assets
have been physically verified by the management during the year and no
serious discrepancies have been noticed on such verification.
C) As per the policy of Company, the temporary site installations for execution of
Job(s) are expensed as project expenditures which is reasonable having
regard to the nature and size of operations.
d) The Company has not disposed off any fixed assets during the year.
2. The nature of business of the Company does not require it to maintain inventories
except for the limited purpose of consumption of chemicals and consumables at
the site locations of customers while executing jobs.
a) As per the information and explanation given to us, the same have been
physically verified by the management at regular intervals.
b) In our opinion and according to the information and examinations given to us,
the procedures of physical verification followed by the management are
reasonable and adequate in relation to the size and nature of its business.
c) On the basis of our examination of the records, we are of the opinion that the
Company is maintaining reasonable proper records in view of the nature and
size of its operations.
3. The Company has not granted or taken any loans, secured or unsecured
to/from companies, firm or other parties covered in the register maintained
under Section 301 of the Companies Act, 1956.
4. In our opinion and according to the information and explanations given to us,
having regard to the explanations that some of the items purchased and
services availed/ rendered are of special nature and suitable alternative
sources do not exist for obtaining comparable quotations, there are adequate
internal control procedures commensurate with the size of the Company and
the nature of business with regard to purchase of inventory and fixed assets
and with regard to the services rendered. During the course of our audit, we
have not observed any continuing major weaknesses in such internal control.
5. The Company has not accepted any deposits from the public under the
meaning of section 58A and 58AA of the Companies Act, 1956 or any other
relevant provision of the Act and the rules framed there under.
ONGC TERI Biotech Limited
6. In our opinion and according to the information and explanations given to us,
the Company is generally regular in depositing undisputed statutory dues
including income tax, sales tax, service tax, custom duty and cess and other
statutory dues, if any with the appropriate authorities. There are no arrears of
outstanding statutory dues as at 31st March 2012 for a period of more than six
months from the date they became payable.
7. The Company has neither accumulated losses nor has incurred cash losses in
the financial year or in the immediately preceding financial year.
8. The Company has not granted loans and advances on the basis of security by
way of pledge of shares and other securities.
9. Based upon the audit procedures performed and as per the information and
explanations given to us by the management, we report that no fraud on or by
the Company has been noticed during the year.
10. The Comment on other matters are required by the Company‟s (Auditor‟s
Report) Order, 2003 are not given as the same are not applicable to the
Company.
For A.K.KHURANA & ASSOCIATES
CHARTERED ACCOUNTANTS
(Registration No.00537IN)
Sd/-
Place: New Delhi (ASHOK KHURANA)
Date: 3rd May,2013 SOLE PRACTITIONER
Membership No.: 084245
ONGC TERI Biotech Limited
BALANCE SHEET AS AT 31ST MARCH, 2013
PARTICULARS
NOTE NO. CURRENT YEAR
(31.03.2013)
PREVIOUS YEAR
(31.03.2012)
I. EQUITY AND LIABILITIES
1 Shareholders’ funds
Share Capital 2 5,00,000 5,00,000
Reserve and Surplus 3 11,71,71,926 7,71,23,633
2 Current liabilities
Trade payables 3,26,42,492 6,69,45,055
Other current liabilities 4 15,88,69,962 11,70,15,140
Short term provisions 5 47,48,745 4,87,277
31,39,33,125 26,20,71,104
II. ASSETS
1 Non-current assets
Fixed Assets
- Tangible Assets 6 48,18,733 53,84,810
Deferred Tax Assets (Net) 1,15,465 1,16,758
Long Term Loan and Advances 7 48,15,000 38,51,100
2 Current assets
Trade Receivables 8 9,36,33,792 6,07,78,987
Cash and Cash Equivalents 9 10,20,55,283 10,63,89,439
Short Term Loan and Advances 10 7,780 76,138
Other Current Assets 11 10,84,87,072 8,54,73,873
31,39,33,125 26,20,71,104
See significant Accounting Policies and accompanying Notes to the Financial Statements
Auditor's Report
As per our report of even date attached
for A .K .KHURANA & ASSOCIATES
CHARTERED ACCOUNTANTS
(Reg.No. 005371N)
Sd/- Sd/- Sd/-
(ASHOK KHURANA) ( N.K.VERMA) (BANWARI LAL)
SOLE PRACTITIONER CHAIRMAN DIRECTOR & CEO
(M. No. 084245)
PLACE :NEW DELHI
DATED : 3rd
May,2013
ONGC TERI Biotech Limited
PROFIT & LOSS STATEMENT FOR THE YEAR ENDED 31ST MARCH, 2013
PARTICULARS NOTE NO. CURRENT YEAR
(31.03.2013)
PREVIOUS YEAR
(31.03.2012)
I. Revenue from projects closed 13,66,05,074 12,99,61,535
II. Other Income 12 82,66,096 88,41,487
III. Total Revenue (I+II) 14,48,71,170 13,88,03,022
IV. Expenses :
Costs on projects closed 7,18,30,357 7,59,38,261
Employee benefits expense 13 78,99,664 67,60,765
Other expenses 14 49,96,038 58,06,735
Depreciation 6 8,60,696 9,31,729
Total Expenses 8,55,86,755 8,94,37,489
V Profit / (Loss) before tax (III-IV) 5,92,84,415 4,93,65,533
VI Tax expense:
Less: Provision for Income Tax 1,92,34,828 1,63,86,233
Less: Income Tax written off - 2,05,700
Add: Deferred Tax Asset (1,293) 11,766
VII Profit / (Loss) after tax (V -VI) 4,00,48,293 3,27,85,366
See significant Accounting Policies and accompanying Notes to the Financial Statements
Auditor's Report
As per our report of even date attached
for A .K .KHURANA & ASSOCIATES
CHARTERED ACCOUNTANTS
(Reg. No. 005371N)
Sd/- Sd/- Sd/-
(ASHOK KHURANA) (N.K.VERMA) (BANWARI LAL)
SOLE PRACTITIONER
(M. No. 084245)
CHAIRMAN DIRECTOR & CEO
PLACE :NEW DELHI
DATED : 3rd
May,2013
ONGC TERI Biotech Limited
STATEMENT OF CASH FLOWS FOR THE PERIOD 1ST APRIL,2012 TO 31ST MARCH, 2013
PARTICULARS CURRENT
YEAR
(31.03.2013)
PREVIOUS
YEAR
(31.03.2012)
Cash Flow from Operating Activities
Net Profit after Tax 4,00,48,293 3,27,85,366
Adjustments for:
Depreciation 8,60,696 9,31,729
Preliminary / Preoperative Expenses w/off 56,133 56,134
Operating Profit before working capital changes 4,09,65,123 3,37,73,228
Adjustments for:
(Increase) / Decrease in Current Assets (5,68,19,680) (5,83,42,418)
Increase / (Decrease) in Current Liabilities 1,18,13,727 5,49,91,969
Deferred Tax Assets 1,293 (11,766)
Net Cash from Operating Activities 'A' (40,39,537) (40,39,537) 3,04,11,013
Cash Flow from Investing Activities
Purchase of Fixed Assets (2,94,619) (10,21,592)
Net Cash utilised in Investing Activities 'B' (2,94,619) (10,21,592)
Cash Flow from Financing Activities
Net Cash utilised in Financing Activities 'C' -
Net Increase / (Decrease) in Cash and Cash
Equivalents (A+B+C)
(43,34,156) 2,93,89,421
Opening Cash and Cash Equivalents 10,63,89,439 7,70,00,018
Closing Balance of Cash and Cash Equivalents 10,20,55,283 10,63,89,439
Cash and Cash Equivalents comprise:
Cash and Bank Balance 10,20,55,283 10,63,89,439
10,20,55,283 10,63,89,439
See significant Accounting Policies and accompanying Notes to the Financial Statements
Auditor's Report
As per our report of even date attached
for A .K .KHURANA & ASSOCIATES
CHARTERED ACCOUNTANTS
(Reg. No. 005371N)
Sd/- Sd/- Sd/-
(ASHOK KHURANA) (N.K.VERMA) (BANWARI LAL)
SOLE PRACTITIONER
(M. No. 084245)
CHAIRMAN DIRECTOR & CEO
PLACE :NEW DELHI
DATED : 3rd
May,2013
ONGC TERI Biotech Limited
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST
MARCH, 2013
1 SIGNIFICANT ACCOUNTING POLICIES
a) Basis of Preparation
The Company has followed mercantile system of accounting and recognizes Income &
Expenditure on accrual basis. The accounts are prepared on historical cost basis, as a
going concern, and are consistent with the generally accepted accounting principles.
b) Use of Estimates
The preparation of financial statements requires estimates and assumptions which affect
the reported amount of assets, liabilities, revenues and expenses of the reporting period.
The difference between the actual results and estimates are recognized in the period in
which the results are known or materialized.
c) Fixed Assets / Depreciation
Fixed assets are stated at historical cost less accumulated depreciation and impairment.
Temporary site installations for execution of job are expensed as project expenditure in
the year in which they are incurred. Depreciation on Fixed Assets has been provided on
written down value basis according to the rates prescribed in Schedule XIV of the
Companies Act, 1956 for the actual period of use.
d) Revenue Recognition
The nature of services rendered by the company is a job comprising of several tasks.
The costs incurred also substantially depend upon the tasks undertaken. The
measurement of stage wise completion based on quantity of work done or costs incurred
are impractical and may reflect distorted results. Therefore, the revenue from projects
based on execution and costs attributable and allocable thereto are recognized on full
completion or substantial completion of the related projects and are billed in accordance
with the contractual terms specified in the contract / agreement. Wherever possible or
applicable, in case the breakup of job into definite tasks along with its proportionate
costs and revenues are available, the revenue is recognized on completion of each task
comprised in the job. However, the invoicing is done on the basis of terms and
conditions specified in the work order and the same may or may not represent the work
completion stage to the extent of invoicing done.
e) Employee Benefits
a) All short term employee benefits (including defined contribution plans) are recognized
at actual cost in the period in which they are incurred.
b)
ONGC TERI Biotech Limited
Since the company has been operative only for 6 years, the discounted value of other
benefits (including terminal and post-retirement benefits) are not recognized, due to its
nominal impact in value terms at this stage.
f) Project Expenses
All direct expenses incurred towards execution of job as well as other general
administrative expenses incurred at site are allocated to the activities/job and
charged/treated in profit and loss statement accordingly.
g) Taxes on Income
Provision for current tax is made as per the provisions of the Income Tax Act, 1961.
Deferred Tax Liability/Asset resulting from ‘timing difference’ between book profit
and taxable profit is accounted for considering the tax rate and laws that have been
enacted or substantially enacted as on the Balance Sheet date.
h) Provisions, Contingent Liabilities and Contingent Assets
Provisions involving substantial degree of estimation in measurement are recognized
when there is a present obligation as a result of past events and it is probable that there
will be an outflow of resources. Contingent Assets are neither recognized nor disclosed
in the financial statements.
2 SHARE CAPITAL
CURRENT YEAR PREVIOUS YEAR
(31.03.2013) (31.03.2012)
AUTHORISED
10,00,000 Equity Shares of Rs.10/- each 1,00,00,000 1,00,00,000
1,00,00,000 1,00,00,000
ISSUED, SUBSCRIBED AND PAID UP
50,000 Equity Shares of Rs.10/-each fully paid
up
5,00,000 5,00,000
5,00,000 5,00,000
The Company has issued only one class of shares referred to as equity shares having a par
value of Rs.10/-
Each holder of equity shares is entitled to one vote per share.
Following are the names of the shareholders together with the number of Equity Shares
holding more than 5 percent of the total Equity Shares:
ONGC TERI Biotech Limited
ONGC 24,990 24, 990
Percentage 49.98 49.98
THE ENERGY & RESOURCES INSTITUTE 24,010 24,010
Percentage 48.02 48.02
3 RESERVES AND SURPLUS
Opening balance 7,71,23,632 4,43,38,266
Add: Net Profit/(Net Loss) for the current year 4,00,48,293 3,27,85,366
Closing balance 11,71,71,926 7,71,23,633
4 OTHER CURRENT LIABILITIES
- Income from Ongoing Projects 15,87,47,176 11,68,92,493
- Other Liabilities 18,472 -
- TDS Payable 1,04,314 1,22,647
15,88,69,962 11,70,15,140
5 SHORT TERM PROVISIONS
- Provision for Taxation 3,56,21,061
Less:- Advance Tax/TDS 3,24,21,411 31,99,650 4,87,277
- Service Tax payable 15,49,095 -
47,48,745 4,87,277
7 LONG TERM LOANS AND ADVANCES
- Security Deposit Against Projects 47,51,650 37,77,750
- Security Deposit Others 63,350 73,350
48,15,000 38,51,100
8 TRADE RECEIVABLES CURRENT
YEAR
PREVIOUS
YEAR
(Unsecured considered good) (31.03.2013) (31.03.2012)
- Trade receivables outstanding for a period exceeding
six months from the date they are due for payment
1,90,21,532
17,487
ONGC TERI Biotech Limited
- Trade receivables outstanding for a period less than
six months from the date they are due for payment
7,46,12,260
9,36,33,792 6,07,61,500
9,36,33,792 6,07,78,987
The amount includes due from ONGC Limited, the investing entity Rs. 74,272,661
(previous year Rs.49,923,147)
9 CASH AND CASH EQUIVALENTS
- Cash-in-Hand 715 715
- Balance with Scheduled Bank 2,48,616 11,46,163
- Fixed Deposit
- held as margin money 3,62,51,144 2,87,07,721
- others 6,55,54,808 7,65,34,840
10,20,55,283 10,63,89,439
10 SHORT TERM LOANS AND ADVANCES
(Unsecured considered good)
- Earnest Money Deposit - 24,000
- Advance to suppliers / others (2,220) 52,138
- Advance to Staff 10,000 -
7,780 76,138
11 OTHER CURRENT ASSETS
- Cost on Ongoing Projects 9,99,92,572 7,74,05,462
- Tax Deducted at Source (against ongoing projects) 39,71,010 22,68,635
- Income Tax Refundable 4,38,151 4,38,151
- Service Tax (Cenvat Credit) - 43,371
- Interest accrued on Fixed Deposit 40,35,339 51,97,954
- Prepaid Expenses 50,000 64,167
- Preliminary / Pre-Operative Expenses - 56,133
10,84,87,072 8,54,73,873
ONGC TERI Biotech Limited
12 OTHER INCOME
- Interest on Fixed Deposit 82,66,096 88,41,487
82,66,096 88,41,487
13 EMPLOYEE BENEFITS EXPENSES
Staff salary, allowances and reimbursement 71,74,363 60,12,518
Employer's contribution to PF and admin. Charges 2,34,834 2,11,830
Group Insurance 3,14,167 3,20,833
Staff Welfare 1,76,300 2,15,584
78,99,664 67,60,765
14 OTHER EXPENSES CURRENT YEAR
(31.03.2013)
PREVIOUS YEAR
(31.03.2012)
Web development & Maintenance Charges 17,771 15,599
Rent-Project / Site office 4,89,710 4,38,660
Books & Periodicals 9,420 9,097
Telephone/Internet Expenses 1,41,619 1,33,993
Courier charges 63,413 87,682
Electricity charges 63,266 52,737
Professional / Consultancy/legal fees 18,11,295 23,89,352
Travelling & Conveyance 9,20,861 10,04,798
Miscellaneous / Sundry Expenses 18,192 1,25,318
Printing Stationery & Computer supplies 2,02,308 1,78,198
Repair & Maintenance-Others 5,22,131 1,78,331
Taxes & Fees 31,149 39,420
Advertisement, Publicity & Business Promotion 98,631 6,16,779
Auditors Remuneration 1,73,325 1,43,100
Bank charges 3,76,814 3,37,537
Preliminary / Preoperative Expenses w/off 56,133 56,134
49,96,038 58,06,735
15 JOINT VENTURE / ASSOCIATES
The Company is a joint venture company formed by ONGC Ltd. in association with The
Energy and Resources Institute, New Delhi, both being investing entities.
16 CONTINGENT LIABILITIES
Outstanding Performance Bank Guarantees issued Rs. 3,60,72,688/-.
(Previous Year Rs. 2,86,88,738)
ONGC TERI Biotech Limited
17 EXPENDITURE INCURRED IN FOREIGN CURRENCY
NIL (Previous year NIL) 18 The details of Auditors remuneration is as under
Audit Fees 1,17,500 97,500
Certification work & other services 46,000 30,000
Out of Pocket Expenses & Service Tax 9,825 15,600
1,73,325 1,43,100
19 The preliminary / preoperative expenses have been written off over a period of five years.
20 Related Party Disclosures
Name Relationship
ONGC Ltd. Investing Entity
The Energy & Resources Institute, New Delhi Investing Entity
Details of Transactions
Services Provided
ONGC 18,08,58,090.00 12,83,81,961.00
(based on invoicing)
Purchases /Services availed
TERI
(based on invoicing) 6,62,55,918.00 7,28,52,997.00
ONGC(Rent) 2,07,790.00 1,98,000.00
Amount Receivable
ONGC Ltd. 7,42,72,661.00 4,99,23,147.00
Amount Payable
TERI 1,99,15,000.00 5,90,10,286.00
Key Management Personnel
No remuneration was paid to key management personnel during current as well as previous
year.
21 Some balances of Trade Receivable / Payable are subject to confirmation / reconciliation.
Adjustments, if any, will be accounted for on confirmation / reconciliation of the same,
which will not have any material impact.
ONGC TERI Biotech Limited
22 Previous Year’s figures have been regrouped / rearranged to make them comparable with
the current year’s figures.
Auditors Report
As per our report of even date
For A.K.KHURANA & ASSOCIATES
CHARTERED ACCOUNTANTS
(Firm Reg. No:005371N)
Sd/- Sd/- Sd/-
(ASHOK KHURANA) (N.K.VERMA) (BANWARI LAL)
SOLE PRACTITIONER
M.No:084245
CHAIRMAN DIRECTOR &CEO
Place : New Delhi
Date : 3rd
May, 2013
ONGC TERI Biotech Limited
DEPRECIATION for the Year 01.04.2012 to 31.03.2013
NOTE-6
Particulars Rate Gross Block Depreciation Net Block
%
As on Additions Sale As on Up to For the Up to As on As on
31.03.2012 31.03.2013 31.03.2012 Year 31.03.2013 31.03.2012 31.03.2013
Computer 40 5,12,225 1,98,709 7,10,934 2,86,727 1,24,647 4,11,374 2,25,498 2,99,560
Equipment
and Field 13.91 59,13,362
45,990
59,59,352 9,67,446 6,91,176
16,58,622 49,45,915 43,00,729
Installations
Furniture 18.10
2,83,539
49,920
3,33,459 70,142 44,873
1,15,015 2,13,397 2,18,444
TOTAL 67,09,125 2,94,619 70,03,744 13,24,315
8,60,696
21,85,011
53,84,810 48,18,733
P .Year
56,87,533.25 10,21,592.00 67,09,125.00
3,92,586.00
9,31,729 13,24,315 52,94,946.70 53,84,809.98
Note 6